1. Home
  2. ACOG vs OPAL Comparison

ACOG vs OPAL Comparison

Compare ACOG & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • OPAL
  • Stock Information
  • Founded
  • ACOG 2000
  • OPAL 1998
  • Country
  • ACOG Canada
  • OPAL United States
  • Employees
  • ACOG N/A
  • OPAL N/A
  • Industry
  • ACOG
  • OPAL Natural Gas Distribution
  • Sector
  • ACOG
  • OPAL Utilities
  • Exchange
  • ACOG Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • ACOG 80.3M
  • OPAL 90.7M
  • IPO Year
  • ACOG N/A
  • OPAL N/A
  • Fundamental
  • Price
  • ACOG $9.33
  • OPAL $2.58
  • Analyst Decision
  • ACOG Strong Buy
  • OPAL Hold
  • Analyst Count
  • ACOG 1
  • OPAL 3
  • Target Price
  • ACOG $20.00
  • OPAL $3.00
  • AVG Volume (30 Days)
  • ACOG 76.9K
  • OPAL 294.6K
  • Earning Date
  • ACOG 08-14-2025
  • OPAL 08-06-2025
  • Dividend Yield
  • ACOG N/A
  • OPAL N/A
  • EPS Growth
  • ACOG N/A
  • OPAL N/A
  • EPS
  • ACOG N/A
  • OPAL 0.02
  • Revenue
  • ACOG $2,928,654.00
  • OPAL $320,427,000.00
  • Revenue This Year
  • ACOG N/A
  • OPAL $22.40
  • Revenue Next Year
  • ACOG N/A
  • OPAL $19.75
  • P/E Ratio
  • ACOG N/A
  • OPAL $126.20
  • Revenue Growth
  • ACOG N/A
  • OPAL 15.22
  • 52 Week Low
  • ACOG $3.75
  • OPAL $1.26
  • 52 Week High
  • ACOG $11.40
  • OPAL $4.45
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • OPAL 40.35
  • Support Level
  • ACOG N/A
  • OPAL $2.45
  • Resistance Level
  • ACOG N/A
  • OPAL $3.40
  • Average True Range (ATR)
  • ACOG 0.00
  • OPAL 0.18
  • MACD
  • ACOG 0.00
  • OPAL -0.11
  • Stochastic Oscillator
  • ACOG 0.00
  • OPAL 13.16

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: